These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 150080)

  • 41. Pretransplant platelet transfusions: their effects on renal allograft outcome and mixed lymphocyte culture reactivity.
    Cahen R; Friedel AC; Betuel H; Adeleine P; Robert F; Trolliet P; Francois B
    Transplantation; 1993 Jun; 55(6):1428-31. PubMed ID: 8516830
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 44. Suppressor cells in human renal allograft recipients.
    Jayavant M; Braun WE; Novick A
    Transplant Proc; 1979 Dec; 11(4):1838-42. PubMed ID: 161099
    [No Abstract]   [Full Text] [Related]  

  • 45. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
    Rashid A; Sengar DP; Harris JE
    Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunological after-care in kidney transplantation].
    Friemel H
    Zentralbl Chir; 1975; 100(20):1241-6. PubMed ID: 174341
    [No Abstract]   [Full Text] [Related]  

  • 48. MLC, PHA, HLA, and DRw studies in renal allografting.
    Braun WE; Jayavant M; Dejelo C; Zachary A; Novick A; Santos N; Williams T
    Transplant Proc; 1979 Dec; 11(4):1911-3. PubMed ID: 161103
    [No Abstract]   [Full Text] [Related]  

  • 49. The elusive middle molecule?
    Hattler BG
    Proc Clin Dial Transplant Forum; 1973; 3():130-4. PubMed ID: 4283132
    [No Abstract]   [Full Text] [Related]  

  • 50. Rapamycin in experimental renal allografts in dogs and pigs.
    Collier DS; Calne R; Thiru S; Lim S; Pollard SG; Barron P; Da Costa M; White DJ
    Transplant Proc; 1990 Aug; 22(4):1674-5. PubMed ID: 2143858
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinico-immunologic problems in kidney transplantation].
    Lanzer G
    Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 53. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of an anti-LFA-1 antibody in renal allograft rejection in sheep.
    Grooby WL; Carter JK; Rao MM; Dewan P; Seymour AE; Brandon M; Russ GR
    Transplant Proc; 1992 Oct; 24(5):2304. PubMed ID: 1413070
    [No Abstract]   [Full Text] [Related]  

  • 55. The correlation of MLC with graft survival.
    Cochrum KC; Perkins HA; Payne RO; Kountz SL; Belzer FO
    Transplant Proc; 1973 Mar; 5(1):391-6. PubMed ID: 4266666
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of methylprednisolone in the modulation of cellular cytotoxicity and its relation to renal transplantation.
    Keown P; Stiller C; Ulan R; Lockie C; McGirr D
    Proc Eur Dial Transplant Assoc; 1978; 15():299-305. PubMed ID: 154100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular function and T cell subsets in patients with long-surviving renal transplants.
    Bakran A; Taylor GM; Read I; Johnson RW; Harris R
    Transplant Proc; 1984 Dec; 16(6):1558-60. PubMed ID: 6239425
    [No Abstract]   [Full Text] [Related]  

  • 59. Correlation between mixed lymphocyte culture performed before renal transplantation and kidney function.
    Bach JF; Debray-Sachs M; Crosnier J; Kreis H; Dormont J
    Clin Exp Immunol; 1970 Jun; 6(6):821-7. PubMed ID: 4920550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
    Wonigkeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.